You have 2 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PERTUZUMAB

Showing 1 - 25 of 355
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-PositiveRecurrent or Metastatic Breast Cancer Trial (SHR-A1811 Injection, SHR-A1811 Injection ; Pertuzumab Injection,

Not yet recruiting
  • HER2-PositiveRecurrent or Metastatic Breast Cancer
  • SHR-A1811 Injection
  • +2 more
  • (no location specified)
Sep 21, 2023

Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Nov 15, 2023

Healthy Men Trial in Moscow (Pertuzumab, Perjeta®)

Not yet recruiting
  • Healthy Men
  • Moscow, Russian Federation
    Central Clinical Hospital "RZD-Medicina"
Apr 11, 2023

Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 12, 2023

Locally Advanced Breast Cancer, Chemo Effect Trial in Beijing (inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP)

Recruiting
  • Locally Advanced Breast Cancer
  • Chemotherapy Effect
  • inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
  • Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 28, 2023

Metastatic HER2-Positive Breast Cancer Trial in United States (Gemcitabine, Trastuzumab, Pertuzumab)

Active, not recruiting
  • Metastatic HER2-Positive Breast Cancer
  • Hartford, Connecticut
  • +4 more
Dec 1, 2022

Breast Cancer Trial in Shanghai (Pertuzumab)

Not yet recruiting
  • Breast Cancer
  • Pertuzumab
  • Shanghai, Shanghai, China
    Shanghai Jiaotong University School of Medicine affiliated Ruiji
Jun 4, 2023

Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab

Active, not recruiting
  • Breast Cancer
  • Pyrotinib Plus Trastuzumab
  • Pertuzumab Plus Trastuzumab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 5, 2022

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Scottsdale, Jacksonville, Rochester

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Stage IVB Prostate Cancer AJCC v8
  • Biopsy
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Feb 15, 2023

Metastatic Breast Cancer Trial (Pertuzumab (ZRC-3277), Pertuzumab (Perjeta®))

Not yet recruiting
  • Metastatic Breast Cancer
  • Pertuzumab (ZRC-3277)
  • Pertuzumab (Perjeta®)
  • (no location specified)
Jul 11, 2022

HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,

Recruiting
  • HER2-positive Breast Cancer
  • +2 more
  • Radiation Therapy
  • +2 more
  • Tampa, Florida
  • +1 more
Dec 30, 2022

HER2-positive Breast Cancer Trial in Guanzhou (Eribulin mesylate injection?Pertuzumab?Trastuzumab)

Recruiting
  • HER2-positive Breast Cancer
  • Eribulin mesylate injection、Pertuzumab、Trastuzumab
  • Guanzhou, Guangdong, China
    LI YuDong
Jul 13, 2023

Breast Cancer Trial in Shanghai (Dalpiciclib, Fulvestrant, Pertuzumab)

Active, not recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 10, 2022

Breast Cancer Trial in Berlin (420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection, Perjeta (EU origin) 420 mg in 14 mL

Recruiting
  • Breast Cancer
  • 420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection
  • +2 more
  • Berlin, Germany
    CRS Clinical Research Services Berlin GmbH
Jul 20, 2022

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Healthy Male Subjects Trial in Auckland, Christchurch (Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC),

Recruiting
  • Healthy Male Subjects
  • Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC)
  • +2 more
  • Adelaide, South Australia, Australia
  • +3 more
Feb 1, 2023

Breast Tumors, Malignant Tumor of the Breast Trial in Multiple Locations (Trastuzumab, Pertuzumab, Vinorelbine, Paclitaxel,

Terminated
  • Breast Neoplasms
  • Malignant Tumor of the Breast
  • Multiple Locations, Texas
    19 Sites
Nov 29, 2022

Breast Cancer Trial in Houston (Durvalumab, Trastuzumab, Pertuzumab)

Recruiting
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
Aug 5, 2022

Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)

Not yet recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Dec 2, 2022

HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

Recruiting
  • HER2 Positive Early Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023

Breast Cancer Trial in Saint Petersburg (BCD-178, Perjeta)

Active, not recruiting
  • Breast Cancer
  • Saint Petersburg, Russian Federation
  • +1 more
Feb 13, 2023

HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

Recruiting
  • HER2-positive Breast Cancer
  • HER-2 pulsed DC1
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 6, 2022

Esophageal Cancer, Esophageal Adenocarcinoma Trial in Amsterdam (Trastuzumab, Pertuzumab, Paclitaxel)

Recruiting
  • Esophageal Cancer
  • Esophageal Adenocarcinoma
  • Amsterdam, Netherlands
    Academic Medical Center
Jun 18, 2022

HER2-positive Breast Cancer Trial in Shanghai (SYSA1901, Pertuzumab, Trastuzumab)

Recruiting
  • HER2-positive Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 8, 2023

Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

Recruiting
  • Brain Metastases
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 8, 2022